I completely agree and support FDA finalizing its guidance on good manufacturing practices for the cosmetics industry.
I fear that, as has been intimated, the current review process that the FDA has would not be adequate to accommodate all...
Legislative solutions that incorporate all stakeholders are more transparent and could be more appropriate to ensuring o...
I'm not certain that the current FDA structure could provide that stability.
We owe a debt of gratitude to the people, both elected officials and citizens, who possessed the foresight to recognize ...
Reforming the IOAS exception through remedial legislation is long overdue, and we urge Congress to act.
The passage of MACRA was a tremendous bipartisan achievement that addressed long-standing and reoccurring problems under...
The College appreciates the opportunity to provide a statement to the Senate Finance Committee that includes our recomme...
The perpetual SGR cycle took up far too much of Congress's time and diverted attention from other priorities.
Getting rid of the SGR not only resolved a vexing problem for lawmakers, it gave security to Medicare beneficiaries.
Most notably, MACRA eliminated the flawed Medicare Sustainable Growth Rate, or SGR, formula.